Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

19

Revenue 2017

Keytruda

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Keytruda was produced by Merck & Co..

AstraZeneca and Daiichi Sankyo announce results for lung cancer therapy

AstraZeneca and Daiichi Sankyo announce results for lung cancer therapy Initial results for the combination therapy – with Merck’s Keytruda – show an overall response rate of 37% in patients with non-small cell lung cancer. ... therapies. The data presented demonstrated an overall response rate of 37% when Dato-DXd was

Merck’s Keytruda receives FDA approval for advanced endometrial cancer

Merck’s Keytruda receives FDA approval for advanced endometrial cancer The trial results showed that patients receiving Keytruda demonstrated an objective response rate of 46%. ... an objective response rate of 46% for certain patients with advanced endometrial carcinoma … treated with Keytruda.”.

Merck’s Keytruda combined with chemotherapy could benefit thousands of breast cancer patients

Merck’s Keytruda combined with chemotherapy could benefit thousands of breast cancer patients with Keytruda, which supplemented standard chemotherapy prior to surgery, with a follow-up treatment using Keytruda after surgery. ... After their surgery, patients continued to receive either Keytruda without chemotherapy, or placebo.

Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment

Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment The study evaluated the combination of Lenvima plus Keytruda versus chemotherapy for patients diagnosed with advanced, metastatic, or recurrent endometrial carcinoma. ... The results presented demonstrated that the combination of Lenvima plus Keytruda

Keytruda gains eighth FDA approval this year

Keytruda gains eighth FDA approval this year Keytruda’s first approval seven years ago was also in melanoma, said Dr Scot Ebbinghaus from Merck Research Laboratories. ... Since then, we have built on this foundation in melanoma and have expanded the use of Keytruda into earlier stages of this

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...